Histochemical Insights into Pancreatic Islet Biology

par Hull, Rebecca L., Baskin, Denis G.
Publié dans J Histochem Cytochem (2015)

The islet endothelial cell: a novel contributor to beta cell secretory dysfunction in diabetes

par Hogan, Meghan F., Hull, Rebecca L.
Publié dans Diabetologia (2017)

Neprilysin Deficiency Is Associated With Expansion of Islet β-Cell Mass in High Fat-Fed Mice

par Parilla, Jacqueline H., Hull, Rebecca L., Zraika, Sakeneh
Publié dans J Histochem Cytochem (2018)

A tale of two pancreases: exocrine pathology and endocrine dysfunction

par Rickels, Michael R., Norris, Andrew W, Hull, Rebecca L.
Publié dans Diabetologia (2020)

Probing the Meaning of Persistent Propeptide Release in Type 1 Diabetes

par Kahn, Steven E., Templin, Andrew T., Hull, Rebecca L., Verchere, C. Bruce
Publié dans Diabetes Care (2019)

Hyaluronan: A Mediator of Islet Dysfunction and Destruction in Diabetes?

par Hull, Rebecca L., Bogdani, Marika, Nagy, Nadine, Johnson, Pamela Y., Wight, Thomas N.
Publié dans J Histochem Cytochem (2015)

Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic mice

par Meier, Daniel T., Morcos, Mary, Samarasekera, Thanya, Zraika, Sakeneh, Hull, Rebecca L., Kahn, Steven E.
Publié dans Diabetologia (2014)

Hyaluronan and Hyaluronan Binding Proteins Are Normal Components of Mouse Pancreatic Islets and Are Differentially Expressed by Islet Endocrine Cell Types

par Hull, Rebecca L., Johnson, Pamela Y., Braun, Kathleen R., Day, Anthony J., Wight, Thomas N.
Publié 2012

GLUCOSE- AND TIME-DEPENDENCE OF ISLET AMYLOID FORMATION IN VITRO

par Zraika, Sakeneh, Hull, Rebecca L., Udayasankar, Jayalakshmi, Utzschneider, Kristina M., Tong, Jenny, Gerchman, Fernando, Kahn, Steven E.
Publié 2007

Human Type 1 Diabetes Is Characterized by an Early, Marked, Sustained, and Islet-Selective Loss of Sympathetic Nerves

par Mundinger, Thomas O., Mei, Qi, Foulis, Alan K., Fligner, Corinne L., Hull, Rebecca L., Taborsky, Gerald J.
Publié dans Diabetes (2016)

INHIBITION OF GLYCOSAMINOGLYCAN SYNTHESIS AND PROTEIN GLYCOSYLATION WITH WAS-406 AND AZASERINE RESULT IN REDUCED ISLET AMYLOID FORMATION IN VITRO

par Hull, Rebecca L., Zraika, Sakeneh, Udayasankar, Jayalakshmi, Kisilevsky, Robert, Szarek, Walter A., Wight, Thomas N., Kahn, Steven E.
Publié 2007

Overall Sulfation of Heparan Sulfate from Pancreatic Islet β-TC3 Cells Increases Maximal Fibril Formation but Does Not Determine Binding to the Amyloidogenic Peptide Islet Amyloid...

par Hull, Rebecca L., Peters, Michael J., Perigo, Susan Potter, Chan, Christina K., Wight, Thomas N., Kinsella, Michael G.
Publié 2012

Matrix Metalloproteinase-9 Reduces Islet Amyloid Formation by Degrading Islet Amyloid Polypeptide

par Aston-Mourney, Kathryn, Zraika, Sakeneh, Udayasankar, Jayalakshmi, Subramanian, Shoba L., Green, Pattie S., Kahn, Steven E., Hull, Rebecca L.
Publié 2013

One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice

par Aston-Mourney, Kathryn, Subramanian, Shoba L., Zraika, Sakeneh, Samarasekera, Thanya, Meier, Daniel T., Goldstein, Lynn C., Hull, Rebecca L.
Publié 2013

Hepatic Insulin Resistance Following Chronic Activation of the CREB Coactivator CRTC2

par Hogan, Meghan F., Ravnskjaer, Kim, Matsumura, Shigenobu, Huising, Mark O., Hull, Rebecca L., Kahn, Steven E., Montminy, Marc
Publié dans J Biol Chem (2015)

HIGH FAT FEEDING UNMASKS VARIABLE INSULIN RESPONSES IN MALE C57BL/6 MOUSE SUBSTRAINS

par Hull, Rebecca L., Willard, Joshua R., Struck, Matthias D., Barrow, Breanne M., Brar, Gurkirat S., Andrikopoulos, Sofianos, Zraika, Sakeneh
Publié dans J Endocrinol (2017)

Human Islets Have Fewer Blood Vessels than Mouse Islets and the Density of Islet Vascular Structures Is Increased in Type 2 Diabetes

par Brissova, Marcela, Shostak, Alena, Fligner, Corinne L., Revetta, Frank L., Washington, Mary K., Powers, Alvin C., Hull, Rebecca L.
Publié dans J Histochem Cytochem (2015)

The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets

par Meier, Daniel T., Entrup, Leon, Templin, Andrew T., Hogan, Meghan F., Mellati, Mahnaz, Zraika, Sakeneh, Hull, Rebecca L., Kahn, Steven E.
Publié dans Diabetologia (2016)

ROSIGLITAZONE TREATMENT DOES NOT DECREASE AMYLOID DEPOSITION IN TRANSPLANTED ISLETS FROM TRANSGENIC MICE EXPRESSING HUMAN ISLET AMYLOID POLYPEPTIDE

par Udayasankar, Jayalakshmi, Zraika, Sakeneh, Aston-Mourney, Kathryn, Subramanian, Shoba L, Brooks-Worrell, Barbara M, Taborsky, Gerald J, Hull, Rebecca L
Publié 2012

Inhibition of Insulin-Degrading Enzyme Does Not Increase Islet Amyloid Deposition in Vitro

par Hogan, Meghan F., Meier, Daniel T., Zraika, Sakeneh, Templin, Andrew T., Mellati, Mahnaz, Hull, Rebecca L., Leissring, Malcolm A., Kahn, Steven E.
Publié dans Endocrinology (2016)